Effects of ibogaine on performance in the 8-arm radial maze.
S Helsley, D Fiorella, R A Rabin, J C Winter
Pharmacology, biochemistry, and behavior September 1, 1997 DOI: 10.1016/s0091-3057(96)00476-5 via PubMed
Summary
AI-generated from the abstractIbogaine, at a potentially neurotoxic dose, did not impair rats' ability to learn or perform a maze task. In a study with 12 rats trained in an 8-arm radial maze, those given ibogaine showed similar learning and accuracy as controls but had lower response rates. When given before maze sessions, ibogaine dose-dependently slowed responding without reducing accuracy. When given after sessions, ibogaine-treated rats made fewer errors than controls. The authors conclude that ibogaine failed to produce any harmful effects on learning or task efficiency.
Study at a glance
| Characteristics | Controlled experiment Peer reviewed |
|---|---|
| Sample size | 12 |
| Population | Rats |
| Intervention | Ibogaine |
| Dose | 50 mg/kg IP administered twice with approximately 8 h between injections; 30 mg/kg IP |
| Citations | 9 |
| Key finding | Ibogaine did not impair acquisition or efficiency in a radial maze task but reduced response rate. |
Abstract
The effects of ibogaine were studied in 12 rats trained to perform in an 8-arm radial maze. In Phase I, the mean number of sessions to criterion and cumulative errors to criterion, as well as mean response rate, were determined for two groups of six animals in a task where only four arms were baited. Group 1 received a potentially neurotoxic dose of ibogaine (50 mg/kg IP administered twice, with approximately 8 h between injections), and group 2 received vehicle. Both groups had similar levels of performance, but ibogaine-treated subjects had a significantly lower rate of responding in the maze. During Phase II, subjects were given a range of doses of ibogaine 20 min prior to working in the maze. Ibogaine produced a dose-dependent decrease in response rate, but efficiency (% arms correct) was not affected. In Phase III, subjects were divided into the same groups as they had been in Phase I. Ibogaine (30 mg/kg, IP) or vehicle was administered immediately following daily sessions in the maze. Ibogaine-treated rats committed significantly fewer errors than those in the vehicle treated group. Thus, in the present study, ibogaine failed to produce any deleterious effects on either acquisition of a novel task or efficiency in a previously learned task.